Immune activation by medium-chain triglyceride-containing lipid emulsions is not modulated by n-3 lipids or toll-like receptor 4

Olthof, E.D.; Gülich, Alexandra Franziska; Renne, Mike F.; Landman, Sija; Joosten, Leo A. B.; Roelofs, Hennie M.J.; Wanten, Geert

doi:10.1016/j.tiv.2015.07.004

Cited by 3 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[43] Nonetheless, their delivery platform (MaxSuppressor in vivo RNA-LANCEr II, BIOO Scientific) containing oil phase and additional small molecules may act as exogenous antigens to randomly stimulate immune cells which can only be used for animal study instead of developing for clinical stages. [44,45] In the present study, QTPlus was also able to deliver AM21 to tumor cells and macrophages and exhibit efficient miR-21 downstream regulations compared with QTsome Original-AM21 (Figure 2). Although the biodistribution studies in the mouse model showed a major accumulation of QTPlus in liver which is similar to other reports on the biodistributions of lipid nanoparticles, [46,47] the significant tumor growth inhibition of QTPlus-AM21 in vitro and in vivo still make it an effective anticancer therapy.…”

Section: Qtplus As An Efficient Platform To Deliver Am21mentioning

confidence: 54%

See 1 more Smart Citation

Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles

Zhang

Huang

Li³

et al. 2022

Adv Healthcare Materials

View full text Add to dashboard Cite

The ability of lipid nanoparticles (LNPs) to deliver nucleic acids have shown a great therapeutic potential to treat a variety of diseases. Here, an optimized formulation of QTsome lipid nanoparticles (QTPlus) is utilized to deliver an anti‐miR‐21 (AM21) against cancer. The miR‐21 downstream gene regulation and antitumor activity is evaluated using mouse and human cancer cells and macrophages. The antitumor activity of QTPlus encapsulating AM21 (QTPlus‐AM21) is further evaluated in combination with erlotinib and atezolizumab (ATZ). QTPlus‐AM21 demonstrates a superior miR‐21‐dependent gene regulation and eventually inhibits A549 non‐small cell lung cancer growth in vitro. QTPlus‐AM21 further induces chemo‐sensitization of A549 cells to erlotinib with a combination index of 0.6 in inhibiting A549 cell growth. When systemically administers to MC38 tumor‐bearing mouse model, QTPlus‐AM21 exhibits an antitumor immune response with over 80% tumor growth inhibition (TGI%) and over twofold and fourfold PD‐1 and PD‐L1 upregulation in tumors and spleens. The combination therapy of QTPlus‐AM21 and ATZ further shows a higher antitumor response (TGI% over 90%) and successfully increases M1 macrophages and CD8 T cells into TME. This study provides new insights into the antitumor mechanism of AM21 and shows great promise of QTPlus‐AM21 in combination with chemotherapies and immunotherapies.

show abstract

Section: Qtplus As An Efficient Platform To Deliver Am21mentioning

confidence: 54%

“…[ 43 ] Nonetheless, their delivery platform (MaxSuppressor in vivo RNA‐LANCEr II, BIOO Scientific) containing oil phase and additional small molecules may act as exogenous antigens to randomly stimulate immune cells which can only be used for animal study instead of developing for clinical stages. [ 44,45 ]…”

Section: Discussionmentioning

confidence: 99%

Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles

Zhang

Huang

Li³

et al. 2022

Adv Healthcare Materials

View full text Add to dashboard Cite

show abstract

“…Other function of oils in NE-based drug delivery is to solubilize hydrophobic agents such as poor water-soluble chemotherapies and immunomodulatory agents (62,63). It has been reported that some of the fusogenic oils (such as mediumchain oils, long-chain oils, and squalene) may stimulate innate immune system by activating toll-like receptors (TLRs) (64)(65)(66). There is no direct evidence showing that oil-induced innate immune activation could lead to antitumor responses in vitro or in vivo.…”

Section: Helper Lipids and Other Componentsmentioning

confidence: 99%

Application of lipid-based nanoparticles in cancer immunotherapy

Zhang

Yao

Hu³

et al. 2022

Front. Immunol.

View full text Add to dashboard Cite

Immunotherapy is revolutionizing the clinical management of patients with different cancer types by sensitizing autologous or allogenic immune cells to the tumor microenvironment which eventually leads to tumor cell lysis without rapidly killing normal cells. Although immunotherapy has been widely demonstrated to be superior to chemotherapies, only a few populations of patients with specific cancer types respond to such treatment due to the failure of systemic immune activation. In addition, severe immune-related adverse events are rapidly observed when patients with very few responses are given higher doses of such therapies. Recent advances of lipid-based nanoparticles (NPs) development have made it possible to deliver not only small molecules but also mRNAs to achieve systemic anticancer immunity through cytotoxic immune cell activation, checkpoint blockade, and chimeric antigen receptor cell therapies, etc. This review summarized recent development and applications of LNPs in anticancer immunotherapy. The diversity of lipid-based NPs would encapsulate payloads with different structures and molecular weights to achieve optimal antitumor immunity through multiple mechanisms of action. The discussion about the components of lipid-based NPs and their immunologic payloads in this review hopefully shed more light on the future direction of anticancer immunotherapy.

show abstract

Structured lipids: Synthesis, health effects, and nutraceutical applications

Zam

2020

Lipids and Edible Oils

View full text Add to dashboard Cite

Immune activation by medium-chain triglyceride-containing lipid emulsions is not modulated by n-3 lipids or toll-like receptor 4

Cited by 3 publications

References 42 publications

Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles

Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles

Application of lipid-based nanoparticles in cancer immunotherapy

Structured lipids: Synthesis, health effects, and nutraceutical applications

Contact Info

Product

Resources

About